
Opinion|Videos|May 21, 2024
Optimizing Transitions of Care for Hepatic Encephalopathy Patients
Key opinion leaders emphasize crucial factors for pharmacists to consider, such as medication costs, staying updated on the latest hepatic encephalopathy (HE) clinical advancements and trials, and understanding disease incidence, which can help prevent recurrence, reduce healthcare costs, and improve patients' cognitive function when managed effectively.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
CagriSema Outperforms Semaglutide in Lowering HbA1C, Reducing Weight Across REIMAGINE Trials
2
FDA Adds a New Sunscreen to the OTC Repertoire
3
Drug Shortages Are Declining, But Persistent Supply Chain Vulnerabilities Continue to Threaten Access
4
FDA Clears First OTC Continuous Glucose Monitor for Children: What Pharmacists Need to Know
5


















































































































